BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 139615)

  • 1. Differentiaton of neuropharmacological actions of apomorphine and d-amphetamine.
    Quock RM; Horita A
    Pharmacol Biochem Behav; 1976 Dec; 5(6):627-31. PubMed ID: 139615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of 5-hydroxytryptaminergic antagonists upon apomorphine- and lergotrile-induced hypothermia and stereotyped behaviour in rats.
    Wade RL; Quock RM; Malone MH
    J Pharm Pharmacol; 1984 Oct; 36(10):673-6. PubMed ID: 6150084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
    Arnt J; Overø KF; Hyttel J; Olsen R
    Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
    Breese GR; Cooper BR; Mueller RA
    Br J Pharmacol; 1974 Oct; 52(2):307-314. PubMed ID: 4155993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apomorphine: modification of its hyperthermic effect in rabbits by p-chlorophenylalanine.
    Quock RM; Horita A
    Science; 1974 Feb; 183(4124):539-40. PubMed ID: 4272136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of serotonin in the mechanism of central action of apomorphine.
    Grabowska M
    Pol J Pharmacol Pharm; 1976; 28(4):389-94. PubMed ID: 790347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.
    Dickinson SL; Gadie B; Tulloch IF
    Psychopharmacology (Berl); 1988; 96(4):521-7. PubMed ID: 2907662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
    Srinivasan J; Schmidt WJ
    J Neural Transm (Vienna); 2005 Sep; 112(9):1223-36. PubMed ID: 15614426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    Yamawaki S; Lai H; Horita A
    J Pharmacol Exp Ther; 1983 Nov; 227(2):383-8. PubMed ID: 6631720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine.
    Fray PJ; Sahakian BJ; Robbins TW; Koob GF; Iversen SD
    Psychopharmacology (Berl); 1980; 69(3):253-9. PubMed ID: 6774363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic effects of apomorphine in rats with altered level of brain serotonin.
    Grabowska M; Michaluk J; Antkiewicz L
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):517-26. PubMed ID: 126051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of low doses of d-amphetamine on drug-induced hyperactivity in the mouse.
    Hussey JS; Vincent ND; Davies JA
    Psychopharmacology (Berl); 1983; 81(4):327-31. PubMed ID: 6228947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
    Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of alpha-adrenergic receptor stimulant drugs on amphetamine or apomorphine-induced stereotypy in rats.
    Zebrowska-Lupina I; Kleinrok Z; Kozyrska C; Wielosz M
    Pol J Pharmacol Pharm; 1978; 30(4):459-67. PubMed ID: 33370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications for multiple transmitter mediation of amphetamine-induced stereotypies.
    Cheal M; Kurkulos ME; Silva L
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1305-8. PubMed ID: 6891794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychotomimetics potentiate locomotor hyperactivity induced by dopaminergic drugs.
    Fink H; Morgenstern R; Oelssner W
    Pharmacol Biochem Behav; 1979 Nov; 11(5):479-82. PubMed ID: 531070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.